UC Berkeley, AB, 12/2000, Molecular and Cell Biology
UC San Francisco, MD, 05/2006
UC San Francisco, Postdoctoral Fellow, 06/2011, Advanced Training in Clinical Research
UC San Francisco, Resident, 06/2013, General Surgery
UC San Francisco, Fellow, 06/2014, Breast Surgical Oncology

Honors & Awards

  • 2003
    Storer Scholarship, UCSF School of Medicine
  • 2005
    Student Research Award, Association for Academic Surgery
  • 2006
    Steinhart Scholarship, UCSF School of Medicine
  • 2007
    Dr Galante Scholarship Award, UCSF Department of Surgery
  • 2009
    Resident Research Scholarship, UCSF CTSI
  • 2013
    Teaching Award for Cherished Housestaff, UCSF School of Medicine
  • 2013
    Lawrence Way Critical Thinking Award, UCSF Department of Surgery

Selected Publications

  1. Abel MK, Shui AM, Chien AJ, Rugo HS, Melisko M, Baehner F, Mukhtar RA. ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer-A National Cancer Database Study. Ann Surg Oncol. 2022 11; 29(12):7750.  View on PubMed
  2. Abel MK, Shui AM, Chien AJ, Rugo HS, Melisko M, Baehner F, Mukhtar RA. The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study. Ann Surg Oncol. 2022 Nov; 29(12):7739-7747.  View on PubMed
  3. Abel MK, Mukhtar RA. ASO Author Reflections: Discordant Clinical and Molecular Risk in Invasive Lobular Carcinoma of the Breast: The 21-Gene Recurrence Score in the National Cancer Database by Histologic Subtype. Ann Surg Oncol. 2022 11; 29(12):7748-7749.  View on PubMed
  4. Mukhtar R, Symmans WF, Esserman LJ. Association of Residual Cancer Burden After Neoadjuvant Therapy and Event-Free Survival in Breast Cancer-Reply. JAMA Oncol. 2022 04 01; 8(4):1.  View on PubMed
  5. Greenberg AL, Sullins VF, Donahue TR, Sundaram VM, Saldinger PF, Divino CM, Anton NE, Stefanidis D, Reilly LM, Egan RJ, Beals CKJ, Riall TS, Duh QY, Mukhtar RA, Hirose K, Lebares CC. Emotional Regulation in Surgery: Fostering Well-Being, Performance, and Leadership. J Surg Res. 2022 09; 277:A25-A35.  View on PubMed
  6. Abel MK, Shui AM, Melisko M, Chien AJ, Yoshida EJ, Lancaster EM, Van 't Veer L, Esserman LJ, Mukhtar RA. The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study. NPJ Breast Cancer. 2021 Dec 21; 7(1):156.  View on PubMed
  7. Naila Dhanani, Oscar Olavarria, Kyung Hyun Lee, Charlotte Young, Frank Primus, Rita Mukhtar, Julie Holihan, Mike Liang, Hobart Harris. O13 BIOLOGIC VERSUS SYNTHETIC MESH IN VENTRAL HERNIA REPAIR: PARTICIPANT-LEVEL ANALYSIS OF TWO RANDOMIZED CONTROLLED TRIALS AT ONE YEAR. British Journal of Surgery. 2021 Nov 24; 108(Supplement_8).  View on PubMed
  8. Rothschild HT, Abel MK, Patterson A, Goodman K, Shui A, van Baelen K, Desmedt C, Benz C, Mukhtar RA. Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer. Breast Cancer Res Treat. 2022 Jan; 191(2):451-458.  View on PubMed
  9. Abel MK, Melisko ME, Rugo HS, Chien AJ, Diaz I, Levine JK, Griffin A, McGuire J, Esserman LJ, Borno HT, Mukhtar RA. Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST? NPJ Breast Cancer. 2021 Oct 25; 7(1):139.  View on PubMed
  10. Yee D, Isaacs C, Wolf DM, Yau C, Haluska P, Giridhar KV, Forero-Torres A, Jo Chien A, Wallace AM, Pusztai L, Albain KS, Ellis ED, Beckwith H, Haley BB, Elias AD, Boughey JC, Kemmer K, Yung RL, Pohlmann PR, Tripathy D, Clark AS, Han HS, Nanda R, Khan QJ, Edmiston KK, Petricoin EF, Stringer-Reasor E, Falkson CI, Majure M, Mukhtar RA, Helsten TL, Moulder SL, Robinson PA, Wulfkuhle JD, Brown-Swigart L, Buxton M, Clennell JL, Paoloni M, Sanil A, Berry S, Asare SM, Wilson A, Hirst GL, Singhrao R, Asare AL, Matthews JB, Hylton NM, DeMichele A, Melisko M, Perlmutter J, Rugo HS, Fraser Symmans W, Van't Veer LJ, Berry DA, Esserman LJ. Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer. NPJ Breast Cancer. 2021 Oct 05; 7(1):131.  View on PubMed
  11. Khoury AL, Keane H, Varghese F, Hosseini A, Mukhtar R, Eder SE, Weinstein PR, Esserman LJ. Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief. NPJ Breast Cancer. 2021 Sep 17; 7(1):123.  View on PubMed
  12. Galstyan A, Bunker MJ, Lobo F, Sims R, Inziello J, Stubbs J, Mukhtar R, Kelil T. Correction to: Applications of 3D printing in breast cancer management. 3D Print Med. 2021 Jul 07; 7(1):19.  View on PubMed
  13. Hewitt KC, Miller P, Piper M, Prionas N, Son JD, Alvarado M, Esserman LJ, Wong JM, Ewing C, Mukhtar RA. Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies. Am J Surg. 2022 04; 223(4):699-704.  View on PubMed
  14. Mary Kathryn Abel, Michelle E. Melisko, Hope S. Rugo, Amy Jo Chien, Italia Diaz, Julia K. Levine, Ann Griffin, Joseph McGuire, Laura Esserman, Hala Borno, Rita A. Mukhtar. Decreased enrollment of patients with advanced lobular breast cancer compared to ductal breast cancer in interventional clinical trials. Journal of Clinical Oncology. 2021 May 20; 39(15_suppl):1092-1092.  View on PubMed
  15. Im CJ, Miller A, Balassanian R, Mukhtar RA. Early onset, multiple, bilateral fibroadenomas of the breast: a case report. BMC Womens Health. 2021 04 21; 21(1):170.  View on PubMed
  16. Rita A. Mukhtar, A. Jo Chien. Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions. Current Breast Cancer Reports. 2021 Apr 12; 1-7.  View on PubMed
  17. Harris HW, Primus F, Young C, Carter JT, Lin M, Mukhtar RA, Yeh B, Allen IE, Freise C, Kim E, Sbitany H, Young DM, Hansen S. Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial. Ann Surg. 2021 04 01; 273(4):648-655.  View on PubMed
  18. Tang A, Cohan CM, Hansen KS, Beattie G, Greenwood HI, Mukhtar RA. Relationship between body mass index and malignancy rates of MRI-guided breast biopsies: impact of clinicodemographic factors. Breast Cancer Res Treat. 2021 Aug; 188(3):739-747.  View on PubMed
  19. Mukhtar RA, Boughey JC. ASO Author Reflections: Changes in Primary Treatment Strategy for Invasive Lobular Carcinoma Highlight the Need for Better Predictors of Therapy Response. Ann Surg Oncol. 2021 10; 28(11):5878-5879.  View on PubMed
  20. Mukhtar RA, Hoskin TL, Habermann EB, Day CN, Boughey JC. Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB). Ann Surg Oncol. 2021 Oct; 28(11):5867-5877.  View on PubMed

Go to UCSF Profiles, powered by CTSI